Theravance News
Most Popular Theravance Story
FDA assess two antibiotics up for review
Reviewers for the FDA say that Theravance's experimental antibiotic telavancin was "possibly" related to some of the deaths reported among volunteers taking the drug. In an analysis released today,... Read more...
Latest Headlines
- November 20, 2008
- November 17, 2008
- July 15, 2008
- April 23, 2008
- March 6, 2008
- March 4, 2008
- October 22, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
